The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumQuick Picks - Catalyst Pharmaceutical Partners (NASDAQ:CPRX) climbed as much as 18% ahead of the bell Wednesday after the company announced that it has licensed the rights to … Continue Reading
Read nowLong Ideas - Acorda Therapeutics (NASDAQ:ACOR) reported 3Q 2012 revenues and EPS of $77.4 million and $0.24, vs. the Consensus estimates of $75.1 million and $0.10, respectively. Sales … Continue Reading
Read nowLong Ideas - In a move that management says will save the company more than $100M over the next three years, AVEO Oncology (NASDAQ:AVEO) cut its work force … Continue Reading
Read nowLong Ideas - Despite a stash of cash and liquid investments, Lexicon Pharmaceuticals (NASDAQ:LXRX) caught investors off guard two weeks ago by initiating a capital raise. The company … Continue Reading
Read nowLong Ideas - Shares of Spectrum Pharmaceuticals (NASDAQ:SPPI) have been under pressure as investors await the supply of generic leucovorin to increase and compete with SPPI’s branded cancer … Continue Reading
Read nowLong Ideas - While investors have been focusing their attention on palifosfamide and the upcoming phase III data, Ziopharm (NASDAQ:ZIOP)Â released some initial phase I data of Ad-RTS IL-12 … Continue Reading
Read nowMost Popular - Our earnings preview supposed that in-line QCOR earnings could improve share price. QCOR delivered well-above estimates, but shares remained flat following, as reimbursement concerns still linger. … Continue Reading
Read now
